Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.42 |
| ▸ | GABRR2 | P28476 | 2/20 | 0.42 |
| ▸ | BLM | P54132 | 2/20 | 0.42 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | APEX1 | P27695 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.36 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1538365 | 1.00 | TSHR (0.42) | TSHRGABRR1GABRR2BLMGABRR3 | |
| SCHEMBL4600709 | 0.92 | THRB (0.40) | TSHRGABRR1GABRR2BLMGABRR3 | |
| SCHEMBL3084515 | 0.90 | TSHR (0.46) | TSHRGABRR1GABRR2BLMGABRR3 | |
| SCHEMBL3084517 | 0.90 | TSHR (0.46) | TSHRGABRR1GABRR2BLMGABRR3 | |
| SCHEMBL2583139 | 0.87 | GABRR1 (0.33) | TSHRGABRR1GABRR2BLMGABRR3 | |
| SCHEMBL1789211 | 0.85 | GABRR1 (0.32) | TSHRGABRR1GABRR2BLMGABRR3 | |
| SCHEMBL14801551 | 0.80 | TSHR (0.46) | TSHRGABRR1GABRR2BLMGABRR3 | |
| SCHEMBL455399 | 0.80 | TSHR (0.46) | TSHRGABRR1GABRR2BLMGABRR3 | |
| SCHEMBL7076723 | 0.77 | GABRR1 (0.35) | TSHRGABRR1GABRR2BLMGABRR3 | |
| SCHEMBL17433692 | 0.77 | PPARA (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3509135-B1 | COMPOSITE MEMBRANE, ANODE STRUCTURE INCLUDING THE COMPOSITE MEMBRANE, LITHIUM BATTERY INCLUDING THE ANODE STRUCTURE, AND METHOD OF PREPARING THE COMPOSITE MEMBRANE | SAMSUNG ELECTRONICS CO LTD (KR) | 2022-04-27 | — | — | EP | claimed |
| EP-2081056-B1 | Laminated diffractive optical element and resin composition therefor | CANON KK (JP) | 2011-01-05 | — | — | EP | claimed |
| US-20030194378-A1 | Novel aerosol formulation containing a polar fluorinated molecule | ASTRAZENECA AB (SE) | 2003-10-16 | — | — | US | claimed |
| EP-1303258-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | AstraZeneca AB (SE) | 2003-04-23 | — | — | EP | claimed |
| WO-2002003958-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | ASTRAZENECA AB (SE) | 2002-01-17 | — | — | WO | claimed |
| US-11156750-B2 | Laminated diffractive optical element and method for manufacturing laminated diffractive optical element | CANON KABUSHIKI KAISHA (JP) | 2021-10-26 | — | — | US | disclosed |
| US-20210223437-A1 | OPTICAL ELEMENT AND METHOD FOR MANUFACTURING THE SAME | CANON KK (JP) | 2021-07-22 | — | — | US | disclosed |
| US-10996375-B2 | Optical element and method for manufacturing the same | CANON KABUSHIKI KAISHA (JP) | 2021-05-04 | — | — | US | disclosed |
| EP-3385760-B1 | OPTICAL ELEMENT AND METHOD FOR MANUFACTURING THE SAME | CANON KK (JP) | 2020-11-11 | — | — | EP | disclosed |
| EP-2482103-B1 | Method of manufacturing a diffractive optical element | NIKON CORP (JP) | 2020-10-28 | — | — | EP | disclosed |
| US-10577446-B2 | Resin precursor composition for optical materials, optical element obtained from the composition, and diffractive optical element configured using the optical element | NIKON CORPORATION (JP) | 2020-03-03 | — | — | US | disclosed |
| EP-3187907-B1 | RESIN PRECURSOR COMPOSITION FOR OPTICAL MATERIALS, OPTICAL ELEMENT OBTAINED FROM SAID COMPOSITION, AND DIFFRACTIVE OPTICAL ELEMENT CONFIGURED USING SAID OPTICAL ELEMENT | NIKON CORP (JP) | 2019-09-25 | — | — | EP | disclosed |
| US-7282525-B2 | Pellicle, producing method thereof and adhesive | MITSUI CHEMICALS, INC. (JP) | 2007-10-16 | — | — | US | disclosed |
| EP-1830205-A1 | CLOSE-BONDED DIFFRACTIVE OPTICAL ELEMENT, OPTICAL MATERIAL USED THEREFOR, RESIN PRECURSOR, AND RESIN PRECURSOR COMPOSITION | Nikon Corporation (JP) | 2007-09-05 | — | — | EP | disclosed |
| EP-1830204-A1 | CLOSE-BONDED DIFFRACTIVE OPTICAL ELEMENT, OPTICAL MATERIAL USED THEREFOR, RESIN PRECURSOR, AND RESIN PRECURSOR COMPOSITION | Nikon Corporation (JP) | 2007-09-05 | — | — | EP | disclosed |
| EP-1303258-B1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | ASTRAZENECA AB (SE) | 2006-10-11 | — | — | EP | disclosed |
| US-20030194378-A1 | Novel aerosol formulation containing a polar fluorinated molecule | ASTRAZENECA AB (SE) | 2003-10-16 | — | — | US | disclosed |
| EP-1303258-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | AstraZeneca AB (SE) | 2003-04-23 | — | — | EP | disclosed |
| US-20020127360-A1 | Pellicle, producing method thereof and adhesive | MITSUI CHEMICALS, INC. (JP) | 2002-09-12 | — | — | US | disclosed |
| WO-2002003958-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | ASTRAZENECA AB (SE) | 2002-01-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10577446-B2 | Resin precursor composition for optical materials, optical element obtained from the composition, and diffractive optical element configured using the optical element | CAD, RARA, RAD51 | TSHR 4637/4885GABRR1 1503/4885GABRR2 1840/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.